sábado, 5 de septiembre de 2026

Analyzing The Federal Trade Commission’s Pharmacy Benefit Manager Settlements Michael A. CarrierandRachel Sachs September 2, 2026

https://www.healthaffairs.org/content/forefront/analyzing-federal-trade-commission-s-pharmacy-benefit-manager-settlements Despite the FTC’s promises, its settlements with PBMs will not be fully effective at accomplishing their stated goals. One concern of note: The settlements neglect the recent development of PBMs marketing their own drugs.

No hay comentarios: